Theriva Biologics, Inc.·4

Dec 15, 4:01 PM ET

Wolf Jeffrey Alan 4

4 · Theriva Biologics, Inc. · Filed Dec 15, 2023

Insider Transaction Report

Form 4
Period: 2023-12-14
Transactions
  • Award

    Stock Options (right to buy)

    2023-12-14+110,000110,000 total
    Exercise: $0.59From: 2024-01-14Exp: 2030-12-14Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]These stock options vest pro rata on a monthly basis over 12 months.

Documents

1 file
  • 4
    tm2332964-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT